Announcements Trials
Browse Landscape

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Recurrence 1Multiple Myeloma 1

Interventions

Specimen Handling 482pembrolizumab 456Magnetic Resonance Spectroscopy 419Carboplatin 322Cyclophosphamide 317Biopsy 270Cisplatin 263Radiotherapy 238Paclitaxel 227Gemcitabine 222Bevacizumab 214Nivolumab 190fludarabine 185venetoclax 172Drug Therapy 165Blood Specimen Collection 157Dexamethasone 156Oxaliplatin 154Injections 152Capecitabine 152Fluorouracil 144Docetaxel 142Standard of Care 138Radiosurgery 136Rituximab 125Pemetrexed 115durvalumab 113atezolizumab 110Leucovorin 110Surveys and Questionnaires 104

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Proteasome Inhibitors × 1 year × Clear all
NCT07051850 2025-07-15

Quality of Life and Treatment Outcomes in RRMM Patients Receiving Advanced vs. Conventional Immunotherapies

Seoul St. Mary's Hospital

Recruiting
174 enrolled
Plasma cell

Multiple Myeloma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡